Hydrogen therapy may be an effective and specific novel treatment for acute graft-versus-host disease (GVHD).
Qian L, Shen J · Journal of cellular and molecular medicine · 2013
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Hydrogen therapy may be an effective and specific novel treatment for acute graft-versus-host disease (GVHD).” is organized in H2HUBB under the research focus hydrogen inhalation oxidative stress study 2013. The publication is cited as Qian L, Shen J, Journal of cellular and molecular medicine, 2013. This animal study examined Hydrogen therapy may be an effective and specific novel treatment for acute graft-versus-host disease (GVHD). The abstract describes Mouse model; hydrogen delivered as hydrogen inhalation. The abstract reports: Besides, the oxidation phenomena and/or the formation of free radicals have been suggested to be causally related to various haematological disorders including aGVHD. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen inhalation oxidative stress study 2013 overview
The main outcome was not fully reported in the available structured record and should be checked against the original source. Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.
Study design and hydrogen intervention
Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Mouse model. Blinding: Unknown. Control status: Unknown.
Delivery method: Hydrogen inhalation.
Reported findings and scientific interpretation
For this hydrogen inhalation oxidative stress study 2013, the study record reports the following: The abstract reports: Besides, the oxidation phenomena and/or the formation of free radicals have been suggested to be causally related to various haematological disorders including aGVHD.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Preclinical animal findings may not translate directly to human outcomes.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.